Page last updated: 2024-09-04

tezosentan and Ventricular Dysfunction, Left

tezosentan has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Z; Danser, AHJ; Duncker, DJ; Garcia-Alvarez, A; Ibanez, B; Merkus, D; Reiss, IKM; Stam, K; Uitterdijk, A; van Duin, RWB1

Other Studies

1 other study(ies) available for tezosentan and Ventricular Dysfunction, Left

ArticleYear
Transition from post-capillary pulmonary hypertension to combined pre- and post-capillary pulmonary hypertension in swine: a key role for endothelin.
    The Journal of physiology, 2019, Volume: 597, Issue:4

    Topics: Animals; Down-Regulation; Endothelins; Endothelium, Vascular; Female; Hypertension, Pulmonary; Lung; Male; Microvessels; Pyridines; Swine; Tetrazoles; Vasodilator Agents; Ventricular Dysfunction, Left

2019